innovation

Texas A&M researchers have harnessed the power of satellites to constantly monitor infrastructure conditions and maintain them.

Now in its second phase, Advancing Discovery to Market provides funding to create new products from recent innovations or discoveries.

Advancing Discovery to Market provides $3.55 million in grants for transforming recent discoveries into new products with commercial potential.

System Chancellor John Sharp and Texas A&M President M. Katherine Banks announced their decision to reorganize and consolidate five commercialization offices.

Siemens recently unveiled an imaging device that promises to detect diseases earlier, allowing for earlier treatment to improve the outlook for patients.

Researchers are looking into drone delivery as a method to efficiently deliver testing kits while limiting contact between individuals.

Through cutting-edge technology, Texas A&M nursing students gain clinical experience before working directly with patients.

Sano Chemicals, founded by Professor of Biology Jim Smith, is focused on treating drug-resistant fungal and bacterial infections.

The Worlds Protect breathalyzer kiosk uses artificial intelligence to “smell” or detect COVID-19 on an exhaled breath. The next step is to make this technology more accessible.

The drug developed by Texas A&M and University of Texas MD Anderson Cancer Center scientists could be an effective treatment for COVID-19 and other illnesses.